Conference Support: The 13th International Drug Delivery Symposium

描述（由申请人提供）：本计划共同主席（作为PI）的提案寻求2007年2月26日至28日在犹他湖城举行的第十三届药物输送系统最新进展国际研讨会上选定的初级和受保护级讲台发言人以及3名研究生海报研究展示奖的支持。 2007年技术药物输送会议的总主题是围绕“克服长期存在的障碍”，更具体地说，重点是解决有效的药物靶向，渗透，配方和疗效的分子，细胞和组织障碍。 该计划的设计保持其高度重视的传统，在组装包括世界知名的制药科学家，生物工程师，工业科学家和临床医生都寻求解决方案，以引人注目的药物输送问题的口头会议。 举办这次会议的总体具体目标是：1）提供丰富、多样化的科学计划，重点关注在几种重要疾病背景下限制药物治疗功效的基础和临床现象（即，2）召集一批演讲者和参与者，包括广泛认可的思想领袖以及年轻、积极、充满活力的教师和研究人员，他们已经以新颖和高质量的工作而闻名。演讲者和会议主席将代表学术和商业药物输送工作：从基础研究和临床应用的观点和领导。 该计划已经成熟，并在这里详细介绍，包括来自代表性不足的科学团体的人员。重点将放在支持较年轻的参与者和参与这些领域的代表性不足的人口。 该小组将同样代表在这些领域工作的教师的性别多样性特征; 3）促进初级和代表性不足的少数民族科学家和在配方，生物技术，基因传递，生物材料，药物靶向，生物共轭和成像领域工作的教师与该领域的杰出高级和国际研究人员之间的互动。 要求为选定的演讲者参加会议的费用和3名青年科学家的海报旅费提供支助。

DESCRIPTION (provided by applicant): This proposal by the Program Co-Chair (as PI) seeks support of selected junior and protected-class podium speakers, and 3 graduate student poster research presentation awards at the Thirteenth International Symposium on Recent Advances in Drug Delivery Systems, Salt Lake City, UT, February 26-28, 2007. The general theme of the 2007 technical drug delivery conference is centered on "overcoming long-standing barriers", more specifically focused on addressing molecular, cellular and tissue barriers to effective drug targeting, penetration, formulation, and efficacy. The program design maintains its highly regarded tradition in assembling oral sessions comprising world-renowned pharmaceutical scientists, bioengineers, industrial scientists, and clinicians all seeking solutions to compelling drug delivery problems. Overall specific aims in producing this meeting are to: 1) Provide a rich, diverse scientific program focusing on both fundamental and clinical phenomena that limit drug therapeutic efficacy in several important disease contexts (i.e., hurdles of translational research), as well as key areas of biotechnology where investigators are proposing solutions to drug delivery, imaging, tissue engineering problems; 2) Gather a group of presenters and participants comprising widely acknowledged thought-leaders as well as younger, aggressive, and vibrant faculty and research trainees already noted for novel and quality work. Speakers and session chairs will represent both academic and commercial drug delivery efforts: perspectives and leadership from both fundamental research and clinical applications. The program is already mature and detailed herein, including persons from underrepresented scientific groups. Emphasis will be placed on supporting the more junior participants and under-represented populations involved in these areas. This group will similarly represent the gender diversity characteristic of faculty working in these areas; 3) Facilitate interactions between junior and under-represented minority scientists and faculty working in the formulation, biotechnology, gene delivery, biomaterials, drug targeting, bio-conjugation and imaging areas with prominent senior and international investigators in the field. Support is requested both for selected speaker participation costs and 3 junior scientist poster travel awards.